Literature DB >> 30263030

Percutaneous Management of Upper Tract Urothelial Carcinoma in a Transplant Kidney.

Tolulope Bakare1, Omer A Raheem2, Rodney Davis1, Samy Heshmat1, Mohamed H Kamel1.   

Abstract

Upper tract urothelial carcinoma (UTUC) accounts for approximately 5% of all urothelial cancers. The gold standard for managing UTUC is radical nephroureterectomy. Management options may vary depending on the overall clinical picture of the patient and it becomes particularly complex when UTUC develops in a transplanted kidney. We herein present a case report of a 56-year-old male with UTUC in a transplant kidney managed percutaneously with successful salvage of the transplant kidney.

Entities:  

Keywords:  Kidney space-occupying lesion; Kidney transplant; Tumor; Ureteroscopy; Urothelial cancer

Year:  2015        PMID： 30263030      PMCID： PMC6151319          DOI： 10.1159/000442841

Source DB:  PubMed          Journal:  Curr Urol        ISSN： 1661-7649


  10 in total

1.  Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.

Authors:  Mark L Cutress; Grant D Stewart; Edward C G Tudor; Eric A Egong; Simon Wells-Cole; Simon Phipps; Ben G Thomas; Antony C P Riddick; S Alan McNeill; David A Tolley
Journal:  J Urol       Date:  2012-12-07       Impact factor: 7.450

2.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

3.  13-year experience with percutaneous management of upper tract transitional cell carcinoma.

Authors:  P E Clark; S B Streem; M A Geisinger
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

4.  Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.

Authors:  Evanguelos Xylinas; Michael Rink; Vitaly Margulis; Talia Faison; Evi Comploj; Giacomo Novara; Jay D Raman; Yair Lotan; Bertrand Guillonneau; Alon Weizer; Armin Pycha; Douglas S Scherr; Christian Seitz; Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz; Francesco Montorsi; Marc Zerbib; Mithat Gönen; Shahrokh F Shariat
Journal:  J Urol       Date:  2012-12-14       Impact factor: 7.450

5.  Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.

Authors:  George N Thalmann; Regula Markwalder; Bernhard Walter; Urs E Studer
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

6.  Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors.

Authors:  J A Martínez-Piñeiro; M J García Matres; L Martínez-Piñeiro
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

7.  A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?

Authors:  Ardeshir R Rastinehad; Michael C Ost; Brian A Vanderbrink; Kathryn L Greenberg; Assaad El-Hakim; Robert Marcovich; Gopal H Badlani; Arthur D Smith
Journal:  Urology       Date:  2008-10-17       Impact factor: 2.649

8.  Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.

Authors:  Umberto Capitanio; Shahrokh F Shariat; Hendrik Isbarn; Alon Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Jay D Raman; Christian Bolenz; Karim Bensalah; Theresa M Koppie; Wassim Kassouf; Mario I Fernández; Philipp Ströbel; Jeffrey Wheat; Richard Zigeuner; Cord Langner; Matthias Waldert; Mototsugu Oya; Charles C Guo; Casey Ng; Francesco Montorsi; Christopher G Wood; Vitaly Margulis; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2009-04-03       Impact factor: 20.096

9.  Imperative indications for conservative management of upper tract transitional cell carcinoma.

Authors:  Amy E Krambeck; R Houston Thompson; Christine M Lohse; David E Patterson; Daniel S Elliott; Michael L Blute
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

10.  Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.

Authors:  Vitaly Margulis; Shahrokh F Shariat; Surena F Matin; Ashish M Kamat; Richard Zigeuner; Eiji Kikuchi; Yair Lotan; Alon Weizer; Jay D Raman; Christopher G Wood
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.